WebJan 1, 2024 · OTL78 is an excellent tumor-specific NIR agent for use in fluorescence-guided radical prostatectomy and FGS of other cancers. Evaluation of Novel Prostate-Specific … WebAug 18, 2024 · This new technique has been applied in a study which aims to find out whether the new substance (OTL78: a fluorescent substance that binds to the prostate …
Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted …
WebOct 15, 2024 · WEST LAFAYETTE, Ind., Oct. 15, 2024 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-... WebCEO of On Target Laboratories, Martin Low, discusses On Target's development of two new drugs: OTL78, for the treatment of prostate cancer that selectively finds, infiltrates and identifies cancer cells, even those hidden below healthy tissue; and On Target’s lead candidate, OTL38, that operates very similarly to OTL78. trials in tainted space zheng shi probe
On Target Laboratories OTL78 for Prostate Cancer - SoundCloud
WebJan 27, 2024 · This technology can be integrated into surgical robots. Kularatne et al developed a novel PSMA-targeted fluorescent tracer named OTL78, which combined a … Webclinical trial for OTL78 in PCa patients will began in 2024. PSMA is also expressed in tumor-associated blood vessels of most of the solid tumors, including lung cancer, colon cancer, and brain tumors but not expressed in healthy blood vessels. Therefore, OTL78 can be used to detect and surgically treat solid tumors other than PCa. WebLife Sciences Research Solutions trials in tainted space weight